MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation
7. Okt. 2020 | Ulf Sengutta
Einsatz des DigestPro zur Brustkrebsforschung
Lesen sie: MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation